Visualization and targeted disruption of protein interactions in living cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24154492.
- Also identified by DOI 10.1038/ncomms3660 and PMC identifier 3826628.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Protein-protein interactions are the basis of all processes in living cells, but most studies of these interactions rely on biochemical in vitro assays. Here we present a simple and versatile fluorescent-three-hybrid (F3H) strategy to visualize and target protein-protein interactions. A high-affinity nanobody anchors a GFP-fusion protein of interest at a defined cellular structure and the enrichment of red-labelled interacting proteins is measured at these sites. With this approach, we visualize the p53-HDM2 interaction in living cells and directly monitor the disruption of this interaction by Nutlin 3, a drug developed to boost p53 activity in cancer therapy. We further use this approach to develop a cell-permeable vector that releases a highly specific peptide disrupting the p53 and HDM2 interaction. The availability of multiple anchor sites and the simple optical readout of this nanobody-based capture assay enable systematic and versatile analyses of protein-protein interactions in practically any cell type and species.
Medical subject headings
- Biological Assay
- Protein Interaction Mapping
- Proto-Oncogene Proteins c-mdm2
- Recombinant Fusion Proteins
- Tumor Suppressor Protein p53